bioRxivImmunology
A Bacterial Bile Acid Metabolite Modulates Treg Activity through the Nuclear Hormone Receptor NR4A1
W. Li, S. Hang, Y. Fang, S. Bae, Y. Zhang, G. Wang, M. D. McCurry, M. Bae, E. A. Franzosa, C. Huttenhower, L. Yao, A. S. Devlin, J. R. Huh
Abstract
Bile acids act as signaling molecules that regulate immune homeostasis, including the differentiation of CD4+ T cells into distinct T cell subsets. The bile acid metabolite isoallolithocholic acid (isoalloLCA) enhances the differentiation of anti-inflammatory regulatory T cells (Treg cells) by facilitating the formation of a permissive chromatin structure in the promoter region of the transcription factor forkhead box P3 (Foxp3). Here, we identify gut bacteria that synthesize isoalloLCA from 3-oxolithocholic acid and uncover a gene cluster responsible for the conversion in members of the abundant human gut bacterial phylum Bacteroidetes. We also show that the nuclear hormone receptor NR4A1 is required for the effect of isoalloLCA on Treg cells. Moreover, the levels of isoalloLCA and its biosynthetic genes are significantly reduced in patients with inflammatory bowel diseases, suggesting that isoalloLCA and its bacterial producers may play a critical role in maintaining immune homeostasis in humans.
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bile acid metabolites control Th17 and Treg cell differentiation
- Human gut bacteria produce TH17-modulating bile acid metabolites
D. Paik, L. Yao, … A. S. Devlin·bioRxiv·Jan 8, 2021
- Ileitis abolishes tolerogenic functions of the enterohepatic bile acid pool
Zhiping Xiao, Kôichi Sudô, … Mark S. Sundrud·bioRxiv·Sep 18, 2026
- A microbial derived bile acid acts as GPBAR1 agonist and RORγt inverse agonist and reverses inflammation in inflammatory bowel disease
Michele Biagioli, Cristina Di Giorgio, … Stefano Fiorucci·Biomedicine & PharmacotherapyPeer-reviewed·Dec 1, 2024
- CAR/Nr1i3 directs T cell adaptation to bile acids in the small intestine
M. L. Chen, X. Huang, … M. S. Sundrud·bioRxiv·Jul 30, 2020
- An engineered Clostridial mini consortium modulates intestinal inflammation
Edward Ionescu, Jack H. Arnold, … Cathryn Nagler‐Anderson·bioRxiv·Aug 18, 2026